A survey of hospitals participating in the Canadian Nosocomial Infection Surveillance Program suggests that these facilities are not adequately prepared for Candida auris, according to an article on the Healio website.
The first multidrug-resistant case of the illness was reported in the country in 2017.
To date, no program has been implemented for systematic surveillance of C. auris in Canada, and data to inform best practices in microbiology and infection prevention and control (IPAC) remain sparse, the article said.
Of the 56 hospitals, 10 had a written policy stating which patients should be screened for C. auris colonization; an additional 11 hospitals suggested some patient screening was needed.
How Curated Art Elevates Senior Care Spaces
The CDC's Guide to Hand Hygiene in Healthcare
Dana-Farber, BIDMC Launch Construction of Dedicated Adult Cancer Hospital
5 Components of an Integrated Safety Culture in Healthcare
NYC Opens Therapeutic Housing Unit for Medically Vulnerable Detainees